nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—MMAA—hindbrain—epilepsy syndrome	0.0104	0.0615	CbGeAlD
Hydroxocobalamin—MMAA—brainstem—epilepsy syndrome	0.00598	0.0353	CbGeAlD
Hydroxocobalamin—MMACHC—head—epilepsy syndrome	0.00504	0.0297	CbGeAlD
Hydroxocobalamin—MMACHC—nervous system—epilepsy syndrome	0.00478	0.0282	CbGeAlD
Hydroxocobalamin—CASP9—telencephalon—epilepsy syndrome	0.00465	0.0274	CbGeAlD
Hydroxocobalamin—MMACHC—central nervous system—epilepsy syndrome	0.0046	0.0271	CbGeAlD
Hydroxocobalamin—MMAB—medulla oblongata—epilepsy syndrome	0.00391	0.0231	CbGeAlD
Hydroxocobalamin—MUT—forebrain—epilepsy syndrome	0.00388	0.0229	CbGeAlD
Hydroxocobalamin—AMN—cerebellum—epilepsy syndrome	0.0037	0.0219	CbGeAlD
Hydroxocobalamin—MMACHC—brain—epilepsy syndrome	0.00365	0.0216	CbGeAlD
Hydroxocobalamin—MMAB—midbrain—epilepsy syndrome	0.00357	0.0211	CbGeAlD
Hydroxocobalamin—MUT—telencephalon—epilepsy syndrome	0.00357	0.0211	CbGeAlD
Hydroxocobalamin—MMAA—head—epilepsy syndrome	0.0033	0.0195	CbGeAlD
Hydroxocobalamin—MTRR—telencephalon—epilepsy syndrome	0.00321	0.0189	CbGeAlD
Hydroxocobalamin—TCN1—head—epilepsy syndrome	0.00315	0.0186	CbGeAlD
Hydroxocobalamin—MMAA—nervous system—epilepsy syndrome	0.00313	0.0185	CbGeAlD
Hydroxocobalamin—MMAB—head—epilepsy syndrome	0.0031	0.0183	CbGeAlD
Hydroxocobalamin—MMAA—central nervous system—epilepsy syndrome	0.00302	0.0178	CbGeAlD
Hydroxocobalamin—AMN—brain—epilepsy syndrome	0.00301	0.0177	CbGeAlD
Hydroxocobalamin—MMAA—cerebellum—epilepsy syndrome	0.00295	0.0174	CbGeAlD
Hydroxocobalamin—MMAB—nervous system—epilepsy syndrome	0.00294	0.0173	CbGeAlD
Hydroxocobalamin—CASP9—head—epilepsy syndrome	0.0029	0.0171	CbGeAlD
Hydroxocobalamin—MMAB—central nervous system—epilepsy syndrome	0.00283	0.0167	CbGeAlD
Hydroxocobalamin—TCN2—head—epilepsy syndrome	0.00283	0.0167	CbGeAlD
Hydroxocobalamin—MUT—medulla oblongata—epilepsy syndrome	0.0028	0.0165	CbGeAlD
Hydroxocobalamin—MTR—telencephalon—epilepsy syndrome	0.0028	0.0165	CbGeAlD
Hydroxocobalamin—MMAB—cerebellum—epilepsy syndrome	0.00277	0.0163	CbGeAlD
Hydroxocobalamin—CASP9—nervous system—epilepsy syndrome	0.00275	0.0162	CbGeAlD
Hydroxocobalamin—TCN2—nervous system—epilepsy syndrome	0.00268	0.0158	CbGeAlD
Hydroxocobalamin—CASP9—central nervous system—epilepsy syndrome	0.00264	0.0156	CbGeAlD
Hydroxocobalamin—CASP9—cerebellum—epilepsy syndrome	0.00258	0.0152	CbGeAlD
Hydroxocobalamin—TCN2—central nervous system—epilepsy syndrome	0.00258	0.0152	CbGeAlD
Hydroxocobalamin—MUT—midbrain—epilepsy syndrome	0.00256	0.0151	CbGeAlD
Hydroxocobalamin—MTRR—medulla oblongata—epilepsy syndrome	0.00252	0.0149	CbGeAlD
Hydroxocobalamin—MUT—spinal cord—epilepsy syndrome	0.0025	0.0148	CbGeAlD
Hydroxocobalamin—MMAA—brain—epilepsy syndrome	0.00239	0.0141	CbGeAlD
Hydroxocobalamin—MTRR—midbrain—epilepsy syndrome	0.0023	0.0136	CbGeAlD
Hydroxocobalamin—MTRR—spinal cord—epilepsy syndrome	0.00225	0.0133	CbGeAlD
Hydroxocobalamin—MMAB—brain—epilepsy syndrome	0.00225	0.0132	CbGeAlD
Hydroxocobalamin—MUT—head—epilepsy syndrome	0.00222	0.0131	CbGeAlD
Hydroxocobalamin—MTR—medulla oblongata—epilepsy syndrome	0.0022	0.013	CbGeAlD
Hydroxocobalamin—MUT—nervous system—epilepsy syndrome	0.00211	0.0124	CbGeAlD
Hydroxocobalamin—CASP9—brain—epilepsy syndrome	0.0021	0.0124	CbGeAlD
Hydroxocobalamin—TCN2—brain—epilepsy syndrome	0.00205	0.0121	CbGeAlD
Hydroxocobalamin—MUT—central nervous system—epilepsy syndrome	0.00203	0.012	CbGeAlD
Hydroxocobalamin—MTR—midbrain—epilepsy syndrome	0.00201	0.0119	CbGeAlD
Hydroxocobalamin—MTRR—head—epilepsy syndrome	0.002	0.0118	CbGeAlD
Hydroxocobalamin—MUT—cerebellum—epilepsy syndrome	0.00198	0.0117	CbGeAlD
Hydroxocobalamin—MTR—spinal cord—epilepsy syndrome	0.00196	0.0116	CbGeAlD
Hydroxocobalamin—MTRR—nervous system—epilepsy syndrome	0.00189	0.0112	CbGeAlD
Hydroxocobalamin—MTRR—central nervous system—epilepsy syndrome	0.00182	0.0108	CbGeAlD
Hydroxocobalamin—MTRR—cerebellum—epilepsy syndrome	0.00178	0.0105	CbGeAlD
Hydroxocobalamin—MTR—head—epilepsy syndrome	0.00174	0.0103	CbGeAlD
Hydroxocobalamin—MTR—nervous system—epilepsy syndrome	0.00165	0.00974	CbGeAlD
Hydroxocobalamin—MUT—brain—epilepsy syndrome	0.00161	0.0095	CbGeAlD
Hydroxocobalamin—MTR—central nervous system—epilepsy syndrome	0.00159	0.00938	CbGeAlD
Hydroxocobalamin—MTR—cerebellum—epilepsy syndrome	0.00155	0.00917	CbGeAlD
Hydroxocobalamin—MTRR—brain—epilepsy syndrome	0.00145	0.00854	CbGeAlD
Hydroxocobalamin—MTR—brain—epilepsy syndrome	0.00126	0.00745	CbGeAlD
Hydroxocobalamin—Urethral disorder—Gabapentin—epilepsy syndrome	0.00036	0.000816	CcSEcCtD
Hydroxocobalamin—Chills—Pregabalin—epilepsy syndrome	0.000359	0.000815	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Valproic Acid—epilepsy syndrome	0.000358	0.000811	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Pregabalin—epilepsy syndrome	0.000358	0.000811	CcSEcCtD
Hydroxocobalamin—Headache—Acetazolamide—epilepsy syndrome	0.000357	0.000809	CcSEcCtD
Hydroxocobalamin—Urticaria—Zonisamide—epilepsy syndrome	0.000356	0.000808	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Clonazepam—epilepsy syndrome	0.000356	0.000808	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Zonisamide—epilepsy syndrome	0.000354	0.000804	CcSEcCtD
Hydroxocobalamin—Agitation—Valproic Acid—epilepsy syndrome	0.000354	0.000804	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000354	0.000803	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000354	0.000802	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Phenytoin—epilepsy syndrome	0.000354	0.000802	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000353	0.000801	CcSEcCtD
Hydroxocobalamin—Angioedema—Valproic Acid—epilepsy syndrome	0.000352	0.000799	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	0.000352	0.000798	CcSEcCtD
Hydroxocobalamin—Mental disorder—Pregabalin—epilepsy syndrome	0.000351	0.000796	CcSEcCtD
Hydroxocobalamin—Pain—Carbamazepine—epilepsy syndrome	0.00035	0.000795	CcSEcCtD
Hydroxocobalamin—Dizziness—Propofol—epilepsy syndrome	0.00035	0.000793	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Levetiracetam—epilepsy syndrome	0.00035	0.000793	CcSEcCtD
Hydroxocobalamin—Pruritus—Fosphenytoin—epilepsy syndrome	0.000349	0.000791	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Diazepam—epilepsy syndrome	0.000349	0.000791	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000349	0.000791	CcSEcCtD
Hydroxocobalamin—Malaise—Valproic Acid—epilepsy syndrome	0.000348	0.000789	CcSEcCtD
Hydroxocobalamin—Urticaria—Clonazepam—epilepsy syndrome	0.000343	0.000779	CcSEcCtD
Hydroxocobalamin—Eye disorder—Gabapentin—epilepsy syndrome	0.000343	0.000778	CcSEcCtD
Hydroxocobalamin—Dizziness—Midazolam—epilepsy syndrome	0.000342	0.000776	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000342	0.000775	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Clonazepam—epilepsy syndrome	0.000342	0.000775	CcSEcCtD
Hydroxocobalamin—Urticaria—Phenytoin—epilepsy syndrome	0.000341	0.000773	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Gabapentin—epilepsy syndrome	0.000341	0.000773	CcSEcCtD
Hydroxocobalamin—Pruritus—Vigabatrin—epilepsy syndrome	0.00034	0.000771	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Phenytoin—epilepsy syndrome	0.000339	0.00077	CcSEcCtD
Hydroxocobalamin—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000339	0.000769	CcSEcCtD
Hydroxocobalamin—Pain—Lamotrigine—epilepsy syndrome	0.000339	0.000768	CcSEcCtD
Hydroxocobalamin—Nausea—Acetazolamide—epilepsy syndrome	0.000338	0.000767	CcSEcCtD
Hydroxocobalamin—Dizziness—Levetiracetam—epilepsy syndrome	0.000338	0.000766	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000338	0.000766	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000337	0.000766	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000337	0.000765	CcSEcCtD
Hydroxocobalamin—Pruritus—Diazepam—epilepsy syndrome	0.000335	0.000759	CcSEcCtD
Hydroxocobalamin—Rash—Propofol—epilepsy syndrome	0.000333	0.000756	CcSEcCtD
Hydroxocobalamin—Dermatitis—Propofol—epilepsy syndrome	0.000333	0.000756	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Gabapentin—epilepsy syndrome	0.000332	0.000752	CcSEcCtD
Hydroxocobalamin—Headache—Propofol—epilepsy syndrome	0.000331	0.000752	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Gabapentin—epilepsy syndrome	0.000331	0.000751	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Zonisamide—epilepsy syndrome	0.00033	0.000749	CcSEcCtD
Hydroxocobalamin—Chills—Gabapentin—epilepsy syndrome	0.000329	0.000747	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000329	0.000746	CcSEcCtD
Hydroxocobalamin—Chest pain—Valproic Acid—epilepsy syndrome	0.000328	0.000745	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000326	0.00074	CcSEcCtD
Hydroxocobalamin—Rash—Midazolam—epilepsy syndrome	0.000326	0.00074	CcSEcCtD
Hydroxocobalamin—Dizziness—Fosphenytoin—epilepsy syndrome	0.000326	0.00074	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000326	0.000739	CcSEcCtD
Hydroxocobalamin—Dermatitis—Midazolam—epilepsy syndrome	0.000326	0.000739	CcSEcCtD
Hydroxocobalamin—Urticaria—Carbamazepine—epilepsy syndrome	0.000325	0.000738	CcSEcCtD
Hydroxocobalamin—Discomfort—Valproic Acid—epilepsy syndrome	0.000324	0.000736	CcSEcCtD
Hydroxocobalamin—Headache—Midazolam—epilepsy syndrome	0.000324	0.000735	CcSEcCtD
Hydroxocobalamin—Pruritus—Felbamate—epilepsy syndrome	0.000324	0.000735	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000324	0.000735	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Diazepam—epilepsy syndrome	0.000324	0.000734	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Pregabalin—epilepsy syndrome	0.000323	0.000734	CcSEcCtD
Hydroxocobalamin—Rash—Levetiracetam—epilepsy syndrome	0.000322	0.000731	CcSEcCtD
Hydroxocobalamin—Dermatitis—Levetiracetam—epilepsy syndrome	0.000322	0.00073	CcSEcCtD
Hydroxocobalamin—Mental disorder—Gabapentin—epilepsy syndrome	0.000322	0.00073	CcSEcCtD
Hydroxocobalamin—Agitation—Pregabalin—epilepsy syndrome	0.00032	0.000727	CcSEcCtD
Hydroxocobalamin—Headache—Levetiracetam—epilepsy syndrome	0.00032	0.000726	CcSEcCtD
Hydroxocobalamin—Erythema—Gabapentin—epilepsy syndrome	0.00032	0.000725	CcSEcCtD
Hydroxocobalamin—Angioedema—Pregabalin—epilepsy syndrome	0.000318	0.000722	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000318	0.000722	CcSEcCtD
Hydroxocobalamin—Dizziness—Vigabatrin—epilepsy syndrome	0.000318	0.000721	CcSEcCtD
Hydroxocobalamin—Pruritus—Zonisamide—epilepsy syndrome	0.000317	0.00072	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000316	0.000717	CcSEcCtD
Hydroxocobalamin—Oedema—Valproic Acid—epilepsy syndrome	0.000315	0.000714	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000315	0.000714	CcSEcCtD
Hydroxocobalamin—Urticaria—Lamotrigine—epilepsy syndrome	0.000315	0.000714	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000315	0.000714	CcSEcCtD
Hydroxocobalamin—Malaise—Pregabalin—epilepsy syndrome	0.000314	0.000713	CcSEcCtD
Hydroxocobalamin—Nausea—Propofol—epilepsy syndrome	0.000314	0.000713	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Felbamate—epilepsy syndrome	0.000313	0.000711	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000313	0.00071	CcSEcCtD
Hydroxocobalamin—Dizziness—Diazepam—epilepsy syndrome	0.000313	0.00071	CcSEcCtD
Hydroxocobalamin—Infection—Valproic Acid—epilepsy syndrome	0.000313	0.000709	CcSEcCtD
Hydroxocobalamin—Rash—Fosphenytoin—epilepsy syndrome	0.000311	0.000705	CcSEcCtD
Hydroxocobalamin—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000311	0.000705	CcSEcCtD
Hydroxocobalamin—Headache—Fosphenytoin—epilepsy syndrome	0.000309	0.000701	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000309	0.0007	CcSEcCtD
Hydroxocobalamin—Nausea—Midazolam—epilepsy syndrome	0.000307	0.000697	CcSEcCtD
Hydroxocobalamin—Tachycardia—Valproic Acid—epilepsy syndrome	0.000307	0.000697	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Zonisamide—epilepsy syndrome	0.000307	0.000696	CcSEcCtD
Hydroxocobalamin—Pruritus—Clonazepam—epilepsy syndrome	0.000306	0.000693	CcSEcCtD
Hydroxocobalamin—Skin disorder—Valproic Acid—epilepsy syndrome	0.000306	0.000693	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000305	0.000692	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Topiramate—epilepsy syndrome	0.000304	0.00069	CcSEcCtD
Hydroxocobalamin—Pruritus—Phenytoin—epilepsy syndrome	0.000304	0.000689	CcSEcCtD
Hydroxocobalamin—Nausea—Levetiracetam—epilepsy syndrome	0.000303	0.000688	CcSEcCtD
Hydroxocobalamin—Rash—Vigabatrin—epilepsy syndrome	0.000303	0.000687	CcSEcCtD
Hydroxocobalamin—Dizziness—Felbamate—epilepsy syndrome	0.000303	0.000687	CcSEcCtD
Hydroxocobalamin—Dermatitis—Vigabatrin—epilepsy syndrome	0.000303	0.000687	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Topiramate—epilepsy syndrome	0.000303	0.000687	CcSEcCtD
Hydroxocobalamin—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000302	0.000685	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000302	0.000685	CcSEcCtD
Hydroxocobalamin—Headache—Vigabatrin—epilepsy syndrome	0.000301	0.000683	CcSEcCtD
Hydroxocobalamin—Rash—Diazepam—epilepsy syndrome	0.000298	0.000677	CcSEcCtD
Hydroxocobalamin—Dermatitis—Diazepam—epilepsy syndrome	0.000298	0.000676	CcSEcCtD
Hydroxocobalamin—Chest pain—Pregabalin—epilepsy syndrome	0.000297	0.000673	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.000297	0.000673	CcSEcCtD
Hydroxocobalamin—Dizziness—Zonisamide—epilepsy syndrome	0.000296	0.000673	CcSEcCtD
Hydroxocobalamin—Headache—Diazepam—epilepsy syndrome	0.000296	0.000672	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Clonazepam—epilepsy syndrome	0.000296	0.000671	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000295	0.000668	CcSEcCtD
Hydroxocobalamin—Agitation—Gabapentin—epilepsy syndrome	0.000294	0.000666	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Phenytoin—epilepsy syndrome	0.000294	0.000666	CcSEcCtD
Hydroxocobalamin—Discomfort—Pregabalin—epilepsy syndrome	0.000293	0.000665	CcSEcCtD
Hydroxocobalamin—Nausea—Fosphenytoin—epilepsy syndrome	0.000293	0.000664	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000292	0.000663	CcSEcCtD
Hydroxocobalamin—Angioedema—Gabapentin—epilepsy syndrome	0.000292	0.000662	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000292	0.000662	CcSEcCtD
Hydroxocobalamin—Pruritus—Carbamazepine—epilepsy syndrome	0.00029	0.000657	CcSEcCtD
Hydroxocobalamin—Rash—Felbamate—epilepsy syndrome	0.000289	0.000655	CcSEcCtD
Hydroxocobalamin—Eye disorder—Topiramate—epilepsy syndrome	0.000289	0.000655	CcSEcCtD
Hydroxocobalamin—Dermatitis—Felbamate—epilepsy syndrome	0.000289	0.000654	CcSEcCtD
Hydroxocobalamin—Malaise—Gabapentin—epilepsy syndrome	0.000288	0.000654	CcSEcCtD
Hydroxocobalamin—Headache—Felbamate—epilepsy syndrome	0.000287	0.000651	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Topiramate—epilepsy syndrome	0.000287	0.00065	CcSEcCtD
Hydroxocobalamin—Dizziness—Clonazepam—epilepsy syndrome	0.000286	0.000648	CcSEcCtD
Hydroxocobalamin—Nausea—Vigabatrin—epilepsy syndrome	0.000286	0.000648	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000284	0.000645	CcSEcCtD
Hydroxocobalamin—Oedema—Pregabalin—epilepsy syndrome	0.000284	0.000645	CcSEcCtD
Hydroxocobalamin—Dizziness—Phenytoin—epilepsy syndrome	0.000284	0.000644	CcSEcCtD
Hydroxocobalamin—Rash—Zonisamide—epilepsy syndrome	0.000283	0.000641	CcSEcCtD
Hydroxocobalamin—Infection—Pregabalin—epilepsy syndrome	0.000283	0.000641	CcSEcCtD
Hydroxocobalamin—Dermatitis—Zonisamide—epilepsy syndrome	0.000282	0.000641	CcSEcCtD
Hydroxocobalamin—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000282	0.00064	CcSEcCtD
Hydroxocobalamin—Nausea—Diazepam—epilepsy syndrome	0.000281	0.000638	CcSEcCtD
Hydroxocobalamin—Headache—Zonisamide—epilepsy syndrome	0.000281	0.000637	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Valproic Acid—epilepsy syndrome	0.00028	0.000636	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Carbamazepine—epilepsy syndrome	0.00028	0.000636	CcSEcCtD
Hydroxocobalamin—Angiopathy—Topiramate—epilepsy syndrome	0.00028	0.000636	CcSEcCtD
Hydroxocobalamin—Pruritus—Lamotrigine—epilepsy syndrome	0.00028	0.000635	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Topiramate—epilepsy syndrome	0.000279	0.000633	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000279	0.000633	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000278	0.000631	CcSEcCtD
Hydroxocobalamin—Tachycardia—Pregabalin—epilepsy syndrome	0.000278	0.00063	CcSEcCtD
Hydroxocobalamin—Chills—Topiramate—epilepsy syndrome	0.000277	0.000629	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000277	0.000628	CcSEcCtD
Hydroxocobalamin—Skin disorder—Pregabalin—epilepsy syndrome	0.000276	0.000627	CcSEcCtD
Hydroxocobalamin—Rash—Clonazepam—epilepsy syndrome	0.000272	0.000618	CcSEcCtD
Hydroxocobalamin—Dermatitis—Clonazepam—epilepsy syndrome	0.000272	0.000617	CcSEcCtD
Hydroxocobalamin—Chest pain—Gabapentin—epilepsy syndrome	0.000272	0.000617	CcSEcCtD
Hydroxocobalamin—Nausea—Felbamate—epilepsy syndrome	0.000272	0.000617	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000272	0.000616	CcSEcCtD
Hydroxocobalamin—Dizziness—Carbamazepine—epilepsy syndrome	0.000271	0.000615	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000271	0.000615	CcSEcCtD
Hydroxocobalamin—Headache—Clonazepam—epilepsy syndrome	0.000271	0.000614	CcSEcCtD
Hydroxocobalamin—Rash—Phenytoin—epilepsy syndrome	0.000271	0.000614	CcSEcCtD
Hydroxocobalamin—Mental disorder—Topiramate—epilepsy syndrome	0.000271	0.000614	CcSEcCtD
Hydroxocobalamin—Dermatitis—Phenytoin—epilepsy syndrome	0.00027	0.000613	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.00027	0.000613	CcSEcCtD
Hydroxocobalamin—Rash—Oxcarbazepine—epilepsy syndrome	0.000269	0.000611	CcSEcCtD
Hydroxocobalamin—Pain—Valproic Acid—epilepsy syndrome	0.000269	0.00061	CcSEcCtD
Hydroxocobalamin—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000269	0.00061	CcSEcCtD
Hydroxocobalamin—Headache—Phenytoin—epilepsy syndrome	0.000269	0.00061	CcSEcCtD
Hydroxocobalamin—Erythema—Topiramate—epilepsy syndrome	0.000269	0.00061	CcSEcCtD
Hydroxocobalamin—Discomfort—Gabapentin—epilepsy syndrome	0.000269	0.00061	CcSEcCtD
Hydroxocobalamin—Headache—Oxcarbazepine—epilepsy syndrome	0.000267	0.000607	CcSEcCtD
Hydroxocobalamin—Nausea—Zonisamide—epilepsy syndrome	0.000266	0.000604	CcSEcCtD
Hydroxocobalamin—Dizziness—Lamotrigine—epilepsy syndrome	0.000262	0.000594	CcSEcCtD
Hydroxocobalamin—Oedema—Gabapentin—epilepsy syndrome	0.000261	0.000592	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000261	0.000592	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000259	0.000588	CcSEcCtD
Hydroxocobalamin—Infection—Gabapentin—epilepsy syndrome	0.000259	0.000588	CcSEcCtD
Hydroxocobalamin—Rash—Carbamazepine—epilepsy syndrome	0.000258	0.000586	CcSEcCtD
Hydroxocobalamin—Dermatitis—Carbamazepine—epilepsy syndrome	0.000258	0.000585	CcSEcCtD
Hydroxocobalamin—Nausea—Clonazepam—epilepsy syndrome	0.000257	0.000582	CcSEcCtD
Hydroxocobalamin—Headache—Carbamazepine—epilepsy syndrome	0.000257	0.000582	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000256	0.00058	CcSEcCtD
Hydroxocobalamin—Nausea—Phenytoin—epilepsy syndrome	0.000255	0.000578	CcSEcCtD
Hydroxocobalamin—Tachycardia—Gabapentin—epilepsy syndrome	0.000255	0.000577	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Pregabalin—epilepsy syndrome	0.000254	0.000575	CcSEcCtD
Hydroxocobalamin—Nausea—Oxcarbazepine—epilepsy syndrome	0.000254	0.000575	CcSEcCtD
Hydroxocobalamin—Skin disorder—Gabapentin—epilepsy syndrome	0.000253	0.000575	CcSEcCtD
Hydroxocobalamin—Urticaria—Valproic Acid—epilepsy syndrome	0.00025	0.000567	CcSEcCtD
Hydroxocobalamin—Rash—Lamotrigine—epilepsy syndrome	0.00025	0.000566	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Topiramate—epilepsy syndrome	0.000249	0.000566	CcSEcCtD
Hydroxocobalamin—Dermatitis—Lamotrigine—epilepsy syndrome	0.000249	0.000566	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000249	0.000564	CcSEcCtD
Hydroxocobalamin—Headache—Lamotrigine—epilepsy syndrome	0.000248	0.000563	CcSEcCtD
Hydroxocobalamin—Agitation—Topiramate—epilepsy syndrome	0.000247	0.00056	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000246	0.000557	CcSEcCtD
Hydroxocobalamin—Nausea—Carbamazepine—epilepsy syndrome	0.000243	0.000552	CcSEcCtD
Hydroxocobalamin—Pain—Pregabalin—epilepsy syndrome	0.000243	0.000552	CcSEcCtD
Hydroxocobalamin—Malaise—Topiramate—epilepsy syndrome	0.000242	0.00055	CcSEcCtD
Hydroxocobalamin—Nausea—Lamotrigine—epilepsy syndrome	0.000235	0.000533	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000234	0.000532	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Gabapentin—epilepsy syndrome	0.000233	0.000527	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000232	0.000526	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Gabapentin—epilepsy syndrome	0.00023	0.000521	CcSEcCtD
Hydroxocobalamin—Chest pain—Topiramate—epilepsy syndrome	0.000229	0.000519	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000227	0.000516	CcSEcCtD
Hydroxocobalamin—Discomfort—Topiramate—epilepsy syndrome	0.000226	0.000513	CcSEcCtD
Hydroxocobalamin—Urticaria—Pregabalin—epilepsy syndrome	0.000226	0.000513	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000225	0.000511	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Pregabalin—epilepsy syndrome	0.000225	0.00051	CcSEcCtD
Hydroxocobalamin—Pain—Gabapentin—epilepsy syndrome	0.000223	0.000506	CcSEcCtD
Hydroxocobalamin—Pruritus—Valproic Acid—epilepsy syndrome	0.000223	0.000505	CcSEcCtD
Hydroxocobalamin—Oedema—Topiramate—epilepsy syndrome	0.000219	0.000498	CcSEcCtD
Hydroxocobalamin—Infection—Topiramate—epilepsy syndrome	0.000218	0.000495	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000215	0.000488	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Topiramate—epilepsy syndrome	0.000215	0.000488	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000215	0.000488	CcSEcCtD
Hydroxocobalamin—Tachycardia—Topiramate—epilepsy syndrome	0.000214	0.000486	CcSEcCtD
Hydroxocobalamin—Skin disorder—Topiramate—epilepsy syndrome	0.000213	0.000483	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Pregabalin—epilepsy syndrome	0.00021	0.000475	CcSEcCtD
Hydroxocobalamin—Dizziness—Valproic Acid—epilepsy syndrome	0.000208	0.000472	CcSEcCtD
Hydroxocobalamin—Urticaria—Gabapentin—epilepsy syndrome	0.000207	0.00047	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Gabapentin—epilepsy syndrome	0.000206	0.000468	CcSEcCtD
Hydroxocobalamin—Pruritus—Pregabalin—epilepsy syndrome	0.000201	0.000456	CcSEcCtD
Hydroxocobalamin—Rash—Valproic Acid—epilepsy syndrome	0.000198	0.00045	CcSEcCtD
Hydroxocobalamin—Dermatitis—Valproic Acid—epilepsy syndrome	0.000198	0.00045	CcSEcCtD
Hydroxocobalamin—Headache—Valproic Acid—epilepsy syndrome	0.000197	0.000447	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Topiramate—epilepsy syndrome	0.000196	0.000444	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Pregabalin—epilepsy syndrome	0.000195	0.000441	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Topiramate—epilepsy syndrome	0.000193	0.000438	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000192	0.000436	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000189	0.00043	CcSEcCtD
Hydroxocobalamin—Dizziness—Pregabalin—epilepsy syndrome	0.000188	0.000427	CcSEcCtD
Hydroxocobalamin—Pain—Topiramate—epilepsy syndrome	0.000188	0.000426	CcSEcCtD
Hydroxocobalamin—Nausea—Valproic Acid—epilepsy syndrome	0.000187	0.000424	CcSEcCtD
Hydroxocobalamin—Pruritus—Gabapentin—epilepsy syndrome	0.000185	0.000419	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Topiramate—epilepsy syndrome	0.000181	0.00041	CcSEcCtD
Hydroxocobalamin—Rash—Pregabalin—epilepsy syndrome	0.000179	0.000407	CcSEcCtD
Hydroxocobalamin—Dermatitis—Pregabalin—epilepsy syndrome	0.000179	0.000406	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Gabapentin—epilepsy syndrome	0.000178	0.000405	CcSEcCtD
Hydroxocobalamin—Headache—Pregabalin—epilepsy syndrome	0.000178	0.000404	CcSEcCtD
Hydroxocobalamin—Urticaria—Topiramate—epilepsy syndrome	0.000174	0.000395	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Topiramate—epilepsy syndrome	0.000173	0.000393	CcSEcCtD
Hydroxocobalamin—Dizziness—Gabapentin—epilepsy syndrome	0.000172	0.000391	CcSEcCtD
Hydroxocobalamin—Nausea—Pregabalin—epilepsy syndrome	0.000169	0.000383	CcSEcCtD
Hydroxocobalamin—Rash—Gabapentin—epilepsy syndrome	0.000164	0.000373	CcSEcCtD
Hydroxocobalamin—Dermatitis—Gabapentin—epilepsy syndrome	0.000164	0.000373	CcSEcCtD
Hydroxocobalamin—Headache—Gabapentin—epilepsy syndrome	0.000163	0.000371	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Topiramate—epilepsy syndrome	0.000162	0.000367	CcSEcCtD
Hydroxocobalamin—Pruritus—Topiramate—epilepsy syndrome	0.000155	0.000352	CcSEcCtD
Hydroxocobalamin—Nausea—Gabapentin—epilepsy syndrome	0.000155	0.000351	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Topiramate—epilepsy syndrome	0.00015	0.000341	CcSEcCtD
Hydroxocobalamin—Dizziness—Topiramate—epilepsy syndrome	0.000145	0.000329	CcSEcCtD
Hydroxocobalamin—Rash—Topiramate—epilepsy syndrome	0.000138	0.000314	CcSEcCtD
Hydroxocobalamin—Dermatitis—Topiramate—epilepsy syndrome	0.000138	0.000314	CcSEcCtD
Hydroxocobalamin—Headache—Topiramate—epilepsy syndrome	0.000137	0.000312	CcSEcCtD
Hydroxocobalamin—Nausea—Topiramate—epilepsy syndrome	0.00013	0.000296	CcSEcCtD
Hydroxocobalamin—MTRR—Disease—CCR5—epilepsy syndrome	3.91e-05	0.0001	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—ALB—epilepsy syndrome	3.89e-05	9.99e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—ALB—epilepsy syndrome	3.89e-05	9.99e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—HMOX1—epilepsy syndrome	3.88e-05	9.96e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—AKT1—epilepsy syndrome	3.88e-05	9.95e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CDC42—epilepsy syndrome	3.87e-05	9.93e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—AKT1—epilepsy syndrome	3.86e-05	9.9e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—SLC2A1—epilepsy syndrome	3.85e-05	9.88e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—AKT1—epilepsy syndrome	3.84e-05	9.86e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—CAT—epilepsy syndrome	3.83e-05	9.83e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—AKT1—epilepsy syndrome	3.82e-05	9.81e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—MTOR—epilepsy syndrome	3.81e-05	9.79e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—IL6ST—epilepsy syndrome	3.81e-05	9.78e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PLCB1—epilepsy syndrome	3.81e-05	9.77e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GAL—epilepsy syndrome	3.8e-05	9.76e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GFAP—epilepsy syndrome	3.8e-05	9.76e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—TH—epilepsy syndrome	3.79e-05	9.73e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—PTGS2—epilepsy syndrome	3.78e-05	9.7e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—AKT1—epilepsy syndrome	3.77e-05	9.67e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GRM5—epilepsy syndrome	3.76e-05	9.65e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CHRM3—epilepsy syndrome	3.76e-05	9.65e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CASP2—epilepsy syndrome	3.76e-05	9.65e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—AKT1—epilepsy syndrome	3.75e-05	9.62e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD40—epilepsy syndrome	3.75e-05	9.62e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—FGF2—epilepsy syndrome	3.73e-05	9.58e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—FGF2—epilepsy syndrome	3.73e-05	9.58e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—ABCB1—epilepsy syndrome	3.73e-05	9.56e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PTGS2—epilepsy syndrome	3.72e-05	9.55e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—AGT—epilepsy syndrome	3.7e-05	9.49e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PRKCB—epilepsy syndrome	3.67e-05	9.43e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—TSC2—epilepsy syndrome	3.63e-05	9.32e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—APOE—epilepsy syndrome	3.62e-05	9.3e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—ALB—epilepsy syndrome	3.62e-05	9.28e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CX3CR1—epilepsy syndrome	3.6e-05	9.25e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—AKT1—epilepsy syndrome	3.6e-05	9.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—AKT1—epilepsy syndrome	3.6e-05	9.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—AKT1—epilepsy syndrome	3.6e-05	9.23e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—SRC—epilepsy syndrome	3.59e-05	9.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—AKT1—epilepsy syndrome	3.56e-05	9.14e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—FGF2—epilepsy syndrome	3.56e-05	9.14e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—APOE—epilepsy syndrome	3.55e-05	9.12e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—HES1—epilepsy syndrome	3.54e-05	9.09e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—POMC—epilepsy syndrome	3.54e-05	9.08e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—POMC—epilepsy syndrome	3.54e-05	9.08e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CHRM2—epilepsy syndrome	3.53e-05	9.07e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—BDKRB1—epilepsy syndrome	3.53e-05	9.07e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CX3CL1—epilepsy syndrome	3.53e-05	9.07e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—AKT1—epilepsy syndrome	3.53e-05	9.06e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HBEGF—epilepsy syndrome	3.52e-05	9.04e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—AKT1—epilepsy syndrome	3.52e-05	9.02e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—FOS—epilepsy syndrome	3.49e-05	8.96e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—GPX1—epilepsy syndrome	3.46e-05	8.89e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—SLC2A1—epilepsy syndrome	3.46e-05	8.88e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—AKT3—epilepsy syndrome	3.46e-05	8.87e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—FYN—epilepsy syndrome	3.44e-05	8.84e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GABBR1—epilepsy syndrome	3.44e-05	8.82e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—JUNB—epilepsy syndrome	3.43e-05	8.81e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—H2AFX—epilepsy syndrome	3.43e-05	8.81e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CASP8—epilepsy syndrome	3.41e-05	8.75e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NOS1—epilepsy syndrome	3.41e-05	8.75e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PTGS2—epilepsy syndrome	3.4e-05	8.74e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PTGS2—epilepsy syndrome	3.4e-05	8.74e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—MTOR—epilepsy syndrome	3.4e-05	8.72e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—MTOR—epilepsy syndrome	3.4e-05	8.72e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	3.38e-05	8.68e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—POMC—epilepsy syndrome	3.37e-05	8.66e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PTGS2—epilepsy syndrome	3.37e-05	8.64e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PTGS2—epilepsy syndrome	3.37e-05	8.64e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—IL6ST—epilepsy syndrome	3.34e-05	8.57e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—AKT1—epilepsy syndrome	3.33e-05	8.54e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NOS2—epilepsy syndrome	3.31e-05	8.5e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—YWHAZ—epilepsy syndrome	3.31e-05	8.5e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HRH3—epilepsy syndrome	3.3e-05	8.46e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—SRC—epilepsy syndrome	3.29e-05	8.44e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—SRC—epilepsy syndrome	3.29e-05	8.44e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—FGF2—epilepsy syndrome	3.29e-05	8.44e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HBEGF—epilepsy syndrome	3.25e-05	8.35e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—OPRM1—epilepsy syndrome	3.24e-05	8.33e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MTOR—epilepsy syndrome	3.24e-05	8.32e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—ALB—epilepsy syndrome	3.22e-05	8.28e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—ALB—epilepsy syndrome	3.22e-05	8.28e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PTGS2—epilepsy syndrome	3.21e-05	8.25e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—S100B—epilepsy syndrome	3.19e-05	8.2e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—AKT3—epilepsy syndrome	3.19e-05	8.19e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CCR5—epilepsy syndrome	3.18e-05	8.17e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—AKT1—epilepsy syndrome	3.18e-05	8.17e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PTGS2—epilepsy syndrome	3.17e-05	8.12e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—HMOX1—epilepsy syndrome	3.17e-05	8.12e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—SOCS3—epilepsy syndrome	3.16e-05	8.12e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDC42—epilepsy syndrome	3.15e-05	8.1e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CAT—epilepsy syndrome	3.12e-05	8.01e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—ADAM10—epilepsy syndrome	3.12e-05	8e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—POMC—epilepsy syndrome	3.11e-05	7.99e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—FGF2—epilepsy syndrome	3.08e-05	7.91e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—ALB—epilepsy syndrome	3.08e-05	7.89e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCR3—epilepsy syndrome	3.06e-05	7.86e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—SRC—epilepsy syndrome	3.06e-05	7.84e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—ABCB1—epilepsy syndrome	3.04e-05	7.8e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—AGT—epilepsy syndrome	3.04e-05	7.8e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MTOR—epilepsy syndrome	2.99e-05	7.68e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NPY—epilepsy syndrome	2.99e-05	7.66e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ATP2A2—epilepsy syndrome	2.99e-05	7.66e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—APOE—epilepsy syndrome	2.98e-05	7.64e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PTGS2—epilepsy syndrome	2.97e-05	7.61e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—TSC2—epilepsy syndrome	2.96e-05	7.6e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—FGF2—epilepsy syndrome	2.96e-05	7.59e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—BCL2—epilepsy syndrome	2.93e-05	7.51e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CDC42—epilepsy syndrome	2.91e-05	7.47e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—APOE—epilepsy syndrome	2.9e-05	7.44e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL18—epilepsy syndrome	2.88e-05	7.4e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCL3—epilepsy syndrome	2.88e-05	7.39e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—OXT—epilepsy syndrome	2.88e-05	7.39e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CRH—epilepsy syndrome	2.88e-05	7.39e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CXCL2—epilepsy syndrome	2.88e-05	7.39e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HSPB1—epilepsy syndrome	2.88e-05	7.39e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—RELA—epilepsy syndrome	2.86e-05	7.34e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—ALB—epilepsy syndrome	2.84e-05	7.29e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—GPX1—epilepsy syndrome	2.82e-05	7.25e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PTGS2—epilepsy syndrome	2.82e-05	7.24e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PTGS2—epilepsy syndrome	2.82e-05	7.24e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—FYN—epilepsy syndrome	2.81e-05	7.21e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—MTOR—epilepsy syndrome	2.81e-05	7.2e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MEF2C—epilepsy syndrome	2.79e-05	7.17e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—RELA—epilepsy syndrome	2.75e-05	7.05e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—SRC—epilepsy syndrome	2.72e-05	6.99e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—SRC—epilepsy syndrome	2.72e-05	6.99e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—IL6ST—epilepsy syndrome	2.72e-05	6.98e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—FGF2—epilepsy syndrome	2.7e-05	6.93e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NOS2—epilepsy syndrome	2.7e-05	6.93e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—YWHAZ—epilepsy syndrome	2.7e-05	6.93e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—MTOR—epilepsy syndrome	2.69e-05	6.91e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PTGS2—epilepsy syndrome	2.69e-05	6.91e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TSC1—epilepsy syndrome	2.68e-05	6.87e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTK2B—epilepsy syndrome	2.68e-05	6.87e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HES1—epilepsy syndrome	2.67e-05	6.84e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCR2—epilepsy syndrome	2.61e-05	6.69e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SST—epilepsy syndrome	2.61e-05	6.69e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NTRK2—epilepsy syndrome	2.61e-05	6.69e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—SRC—epilepsy syndrome	2.6e-05	6.67e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—FYN—epilepsy syndrome	2.59e-05	6.65e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—H2AFX—epilepsy syndrome	2.58e-05	6.63e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—DUSP6—epilepsy syndrome	2.58e-05	6.63e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—POMC—epilepsy syndrome	2.56e-05	6.56e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ADRA2A—epilepsy syndrome	2.55e-05	6.54e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PLAT—epilepsy syndrome	2.54e-05	6.52e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—JUN—epilepsy syndrome	2.51e-05	6.43e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—YWHAZ—epilepsy syndrome	2.49e-05	6.4e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTGS2—epilepsy syndrome	2.48e-05	6.37e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—AGT—epilepsy syndrome	2.48e-05	6.36e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MTOR—epilepsy syndrome	2.46e-05	6.31e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—BDKRB2—epilepsy syndrome	2.45e-05	6.29e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CXCL12—epilepsy syndrome	2.45e-05	6.29e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—AKT1—epilepsy syndrome	2.45e-05	6.29e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTGS2—epilepsy syndrome	2.44e-05	6.25e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—APOE—epilepsy syndrome	2.43e-05	6.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CRP—epilepsy syndrome	2.41e-05	6.2e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—TSC2—epilepsy syndrome	2.41e-05	6.2e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CNR1—epilepsy syndrome	2.4e-05	6.17e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—JUNB—epilepsy syndrome	2.4e-05	6.17e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—SRC—epilepsy syndrome	2.4e-05	6.16e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CCR5—epilepsy syndrome	2.4e-05	6.15e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PLCB1—epilepsy syndrome	2.4e-05	6.15e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HTR7—epilepsy syndrome	2.35e-05	6.02e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—ALB—epilepsy syndrome	2.33e-05	5.98e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HBEGF—epilepsy syndrome	2.28e-05	5.84e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—SRC—epilepsy syndrome	2.25e-05	5.77e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKT3—epilepsy syndrome	2.24e-05	5.74e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—AKT1—epilepsy syndrome	2.23e-05	5.73e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TSC2—epilepsy syndrome	2.23e-05	5.72e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PRKCB—epilepsy syndrome	2.23e-05	5.72e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL6ST—epilepsy syndrome	2.22e-05	5.7e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—FGF2—epilepsy syndrome	2.2e-05	5.65e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ADAM10—epilepsy syndrome	2.18e-05	5.6e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—APOE—epilepsy syndrome	2.18e-05	5.6e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—SRC—epilepsy syndrome	2.16e-05	5.54e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—POMC—epilepsy syndrome	2.08e-05	5.35e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—S100B—epilepsy syndrome	2.06e-05	5.3e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—IL6ST—epilepsy syndrome	2.05e-05	5.26e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SOCS3—epilepsy syndrome	2.04e-05	5.25e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—AKT1—epilepsy syndrome	2.04e-05	5.24e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—AKT1—epilepsy syndrome	2.04e-05	5.24e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CDC42—epilepsy syndrome	2.04e-05	5.23e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTGS2—epilepsy syndrome	2.04e-05	5.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—FOS—epilepsy syndrome	2.03e-05	5.22e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NOS2—epilepsy syndrome	2.03e-05	5.22e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MTOR—epilepsy syndrome	2e-05	5.14e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CASP8—epilepsy syndrome	1.99e-05	5.1e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTGS2—epilepsy syndrome	1.99e-05	5.1e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AVP—epilepsy syndrome	1.97e-05	5.07e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—SRC—epilepsy syndrome	1.97e-05	5.05e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—ALB—epilepsy syndrome	1.9e-05	4.88e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—AKT1—epilepsy syndrome	1.9e-05	4.87e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—AKT1—epilepsy syndrome	1.87e-05	4.8e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HES1—epilepsy syndrome	1.87e-05	4.79e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FYN—epilepsy syndrome	1.82e-05	4.66e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—H2AFX—epilepsy syndrome	1.81e-05	4.64e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MEF2C—epilepsy syndrome	1.81e-05	4.63e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—FGF2—epilepsy syndrome	1.79e-05	4.61e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—YWHAZ—epilepsy syndrome	1.75e-05	4.48e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NGF—epilepsy syndrome	1.73e-05	4.43e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—AKT1—epilepsy syndrome	1.71e-05	4.39e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—AKT1—epilepsy syndrome	1.71e-05	4.39e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—BCL2—epilepsy syndrome	1.7e-05	4.37e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—AKT1—epilepsy syndrome	1.69e-05	4.34e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—AKT1—epilepsy syndrome	1.69e-05	4.34e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCR5—epilepsy syndrome	1.68e-05	4.31e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—RELA—epilepsy syndrome	1.67e-05	4.28e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTGS2—epilepsy syndrome	1.66e-05	4.27e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—FGF2—epilepsy syndrome	1.66e-05	4.25e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HTR2A—epilepsy syndrome	1.64e-05	4.22e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MTOR—epilepsy syndrome	1.63e-05	4.19e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—AKT1—epilepsy syndrome	1.62e-05	4.14e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—SRC—epilepsy syndrome	1.61e-05	4.12e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—AKT1—epilepsy syndrome	1.59e-05	4.08e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TSC2—epilepsy syndrome	1.56e-05	4.01e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AGT—epilepsy syndrome	1.56e-05	4e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—APOE—epilepsy syndrome	1.53e-05	3.92e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MTOR—epilepsy syndrome	1.51e-05	3.87e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL1B—epilepsy syndrome	1.51e-05	3.87e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KDR—epilepsy syndrome	1.5e-05	3.84e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTGS2—epilepsy syndrome	1.49e-05	3.84e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—AKT1—epilepsy syndrome	1.49e-05	3.83e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—JUN—epilepsy syndrome	1.46e-05	3.75e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PRKCB—epilepsy syndrome	1.44e-05	3.7e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL6ST—epilepsy syndrome	1.43e-05	3.68e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—AKT1—epilepsy syndrome	1.42e-05	3.64e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—AKT1—epilepsy syndrome	1.42e-05	3.64e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—AKT1—epilepsy syndrome	1.4e-05	3.59e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—AKT1—epilepsy syndrome	1.35e-05	3.47e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—AKT1—epilepsy syndrome	1.34e-05	3.44e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—POMC—epilepsy syndrome	1.31e-05	3.37e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—SRC—epilepsy syndrome	1.31e-05	3.36e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCL2—epilepsy syndrome	1.28e-05	3.3e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—AKT1—epilepsy syndrome	1.25e-05	3.2e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—AKT1—epilepsy syndrome	1.22e-05	3.14e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—SRC—epilepsy syndrome	1.21e-05	3.1e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FGF2—epilepsy syndrome	1.16e-05	2.98e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—RELA—epilepsy syndrome	1.08e-05	2.76e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MTOR—epilepsy syndrome	1.06e-05	2.71e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—AKT1—epilepsy syndrome	1.03e-05	2.63e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—AKT1—epilepsy syndrome	9.98e-06	2.56e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CASP3—epilepsy syndrome	9.72e-06	2.49e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—JUN—epilepsy syndrome	9.44e-06	2.42e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MMP9—epilepsy syndrome	9.18e-06	2.36e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SRC—epilepsy syndrome	8.46e-06	2.17e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—AKT1—epilepsy syndrome	8.36e-06	2.14e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—VEGFA—epilepsy syndrome	8.24e-06	2.12e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—AKT1—epilepsy syndrome	8.14e-06	2.09e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—AKT1—epilepsy syndrome	7.51e-06	1.93e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKT1—epilepsy syndrome	5.26e-06	1.35e-05	CbGpPWpGaD
